Proprius Pharmaceuticals is a specialty pharma company which develops personalized medicine solutions in rheumatology and autoimmune diseases.
In Latin, the word proprius means, “one’s own”, and forms the basis for the word “appropriate”.
By bringing together unique therapeutics, pharmacogenetics, diagnostic and prognostic services, Proprius Pharmaceuticals facilitates optimal treatment decisions to help physicians improve patient care.
The highly experienced Proprius Pharma management team has a proven track record of licensing, managing clinical development and successfully commercializing specialty pharmaceutical products.
The Proprius team has demonstrated its strengths in creating new markets and growing therapeutic and diagnostic products. Proprius is a privately-held and venture-backed organization.